2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
US7893063B2 · kind B2 · utility
11Cited by
1References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 7, 2005 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Jan 3, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns pyrimidine derivatives of Formula (I) wherein each of Qa, G1, G2, q, R3, r, R4, X1 and Qb have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the production of an anti-proliferative effect in a warm-blooded animal such as man.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.